Excellence at the point of care

We are committed to helping pioneer a new era in diagnostic technology, where the results from DNA and RNA-based tests can be obtained in the moment of need, at the point of care.

TEST TO TREAT

To keep life moving forward, even as new variants may continue to emerge, COVID-19 testing remains important to ensure appropriate patient management and supports the government’s Test to Treat initiative.

Learn More

COMPLEMENT YOUR COVID-19 TESTING PROGRAMS

Whether you need an antigen or molecular test, we deliver rapid, accurate testing solutions in a variety of healthcare settings.

Learn More

One system, multiple applications

With access to lab-quality molecular diagnostics at the point of need, clinicians get timely results for actionable decision making. In the future, our portfolio of point-of-care diagnostic tests will include solutions for multiple infectious disease states in a variety of settings.

Learn More

COVID-19

Meeting the changing needs of the rapidly evolving COVID-19 pandemic

Influenza

Developing a new option for molecular point-of-care influenza testing

Chlamydia

Building a test that addresses the real-world challenges of reducing the spread of sexually transmitted infections

Gonorrhea

Working to reduce the spread of gonorrhea by developing a rapid and accurate point-of-care test

Recent Blog Articles

Article
June 15, 2022

Sexually Transmitted Infections and Disease: the Silent Pandemic

Twenty-five years ago, the Institute of Medicine (IOM) published a report on confronting sexually transmitted diseases (STDs) as the “hidden epidemic of tremendous health and economic consequence in the United…
Article
May 13, 2022

COVID-19: It’s Not Over Yet

It’s hard to believe that it’s been more than 2 years since the World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. At that time, the…
Article
March 16, 2022

COVID-19 Testing for Travel—What Your Patients Need to Know

Whether upcoming travel is for relaxation, business, or a combination of both, testing for COVID-19 is likely an integral part of the trip, especially when traveling by air. There are…
Article
February 22, 2022

Omicron and COVID-19 testing: What healthcare providers need to know

As the SARS-CoV-2 omicron variant (B.1.1.529) rapidly became the dominant strain in South Africa in late 2021, public health officials around the globe recognized that a new, highly transmissible form…

Join Our Newsletter

Subscribe to our newsletter for information about our products and company updates.

    TALIS BIOMEDICAL

    The GenBody COVID-19 Ag Test and the Talis One COVID-19 Test System are for use under Emergency Use Authorization (EUA) only. For In Vitro Diagnostic (IVD) use. For prescription use only. Talis is an authorized distributor of the GenBody COVID-19 Ag test.

    © Talis and Talis One are trademarks of Talis Biomedical Corporation. All Rights Reserved.

    *Additional testing solutions are currently in development and not available for sale.